Small molecules as tools for functional assessment of deubiquitinating enzyme function

Robert S Magin1, Xiaoxi Liu1, Alejandra Felix1

  • 1Department of Cancer Biology and the Linde Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02215, USA.

Summary

Small-molecule inhibitors are revolutionizing the study of deubiquitinating enzymes (DUBs). These potent compounds enable researchers to explore the critical roles of DUBs in cellular processes and disease, advancing pharmacological research.